The clinical evaluation of the acceptance of fluticasone propionate Diskus® by older Japanese patients with bronchial asthma

Allergology International

Volumn 54, Issue 3, 2005, Pages 411-418

  Ohbayashi, Hiroyuki ^a,b  

^a JA Gifu Tohno Kousei Hospital   (Japan)

^b JA Gifu Tohno Kousei Hospital   (Japan)

Author keywords

Asthma; Drug compliance; Fluticasone propionate Diskus ; Older patients

Indexed keywords

BECLOMETASONE DIPROPIONATE; FLUTICASONE PROPIONATE;

ADULT; AGED; AGING; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; EQUIPMENT DESIGN; FEMALE; HUMAN; INHALER; INTERMETHOD COMPARISON; JAPAN; LUNG FUNCTION TEST; MALE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 25144507627     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.2332/allergolint.54.411     Document Type: Article

References (14)

1. Numao T, Fukuda T. Japanese guideline for the diagnosis and management of bronchial asthma (1998)-Its results and reversion. Nippon Rinsho 2001;59:1871-1877.
2. National Institutes of Health, National Heart Lung and Blood Institute. Global Initiative for asthma. Global strategy for asthma management and prevention. Bethesda: National Institutes of Health, 2002; 102-114.
3. Haahtela T. Early treatment in asthma: How early is early? Allergol. Int. 2002;51:75-83.
4. Barnes PJ. Inhaled glucocorticoids: New developments relevant to updating of the asthma management guidelines. Respir. Med. 1996;90:379-384.
5. Staresinic AG, Sorkness CA. Fluticasone propionate: A potent inhaled corticosteroid for the treatment of asthma. Expert Opin. Pharmacother. 2000;1:1227-1244.
6. O'Connell EJ. Efficacy of budesonide in moderate to severe asthma. Clin. Ther. 2002;24:887-905.
7. Banov CH. The role of budesonide in adults and children with mild-to-moderate persistent asthma. J. Asthma 2004; 41:5-17.
8. Ohbayashi H, Yamase H. An evaluation of the acceptance of budesonide turbuhaler by older Japanese patients with bronchial asthma when changed from fluticasone propionate (FP) or beclomethasone dipropionate (BDP). Arerugi 2003;52:31-38.
9. Labiris NR, Dolovich MB. Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br. J. Clin. Pharmacol. 2003;56:600-612.
10. Newman SP. Dry powder inhalers for optimal drug delivery. Expert Opin. Biol. Ther. 2004;4:23-33.
11. Dalby R, Suman J. Inhalation therapy: technological milestones in asthma treatment. Adv. Drug Deliv. Rev. 2003; 55:779-791.
12. Allen SC, Prior A. What determines whether an elderly patient can use a metered dose inhaler correctly? Br. J. Dis. Chest 1986;80:45-49.
13. Allen SC, Ragab S. Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad. Med. J. 2002;78:37-39.
14. Boulet LP, Cowie R, Johnston P, Krakovsky D, Mark S. Comparison of Diskus inhaler, a new multidose powder inhaler, with Diskhaler® inhaler for the delivery of salmeterol to asthmatic patients. Canadian Study Group. J. Asthma 1995;32:429-436.